-
1
-
-
84885906494
-
Dementia
-
Self Management of Chronic Disease
-
Ilkin I, Ignat P. Dementia. Self Management of Chronic Disease 2009; 29-41.
-
(2009)
, pp. 29-41
-
-
Ilkin, I.1
Ignat, P.2
-
2
-
-
84885909125
-
Preventing Alzheimer disease and cognitive decline: evidence report/technology assessment, NO.193
-
Duke Evidence-based Practice Center
-
Williams JW, Plassman BL, Burke J, Holsinger T, Benjamin S. Preventing Alzheimer disease and cognitive decline: evidence report/technology assessment, NO.193. Duke Evidence-based Practice Center 2007.
-
(2007)
-
-
Williams, J.W.1
Plassman, B.L.2
Burke, J.3
Holsinger, T.4
Benjamin, S.5
-
3
-
-
0019991994
-
The impact of dementia on the family
-
Peter VR, Nancy LM, Mary JL. The impact of dementia on the family. JAMA 1982; 248: 333-335.
-
(1982)
JAMA
, vol.248
, pp. 333-335
-
-
Peter, V.R.1
Nancy, L.M.2
Mary, J.L.3
-
4
-
-
77954556989
-
Can statins prevent or help treat Alzheimer's disease?
-
Bernadette MG, Peter P. Can statins prevent or help treat Alzheimer's disease? J Alzheimers Dis Other Demen 2010; 20: 925-933.
-
(2010)
J Alzheimers Dis Other Demen
, vol.20
, pp. 925-933
-
-
Bernadette, M.G.1
Peter, P.2
-
5
-
-
0031976318
-
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
-
Notkola IL, Sulkava R, Pekkanen J etal. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17: 14-20.
-
(1998)
Neuroepidemiology
, vol.17
, pp. 14-20
-
-
Notkola, I.L.1
Sulkava, R.2
Pekkanen, J.3
-
6
-
-
0033958076
-
Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans
-
Evans RM, Emsley CL, Gao S etal. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology 2000; 54: 240-242.
-
(2000)
Neurology
, vol.54
, pp. 240-242
-
-
Evans, R.M.1
Emsley, C.L.2
Gao, S.3
-
7
-
-
33644911218
-
Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba
-
Hall K, Murrell J, Ogunniyi A etal. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology 2006; 66: 223-227.
-
(2006)
Neurology
, vol.66
, pp. 223-227
-
-
Hall, K.1
Murrell, J.2
Ogunniyi, A.3
-
8
-
-
0034638746
-
Statins and the risk of dementia
-
Jick H, Zornberg GL, Jick S, Sesharia S, Drachman DA. Statins and the risk of dementia. Lancet 2000; 356: 1627-1631.
-
(2000)
Lancet
, vol.356
, pp. 1627-1631
-
-
Jick, H.1
Zornberg, G.L.2
Jick, S.3
Sesharia, S.4
Drachman, D.A.5
-
9
-
-
33847389770
-
Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis
-
Zhou B, Teramukai S, Fukushima M. Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. Dement Geriatr Cogn Disord 2007; 23: 194-201.
-
(2007)
Dement Geriatr Cogn Disord
, vol.23
, pp. 194-201
-
-
Zhou, B.1
Teramukai, S.2
Fukushima, M.3
-
10
-
-
0034685429
-
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group
-
Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
-
(2000)
JAMA
, vol.283
, pp. 2008-2012
-
-
Stroup, D.F.1
Berlin, J.A.2
Morton, S.C.3
-
11
-
-
0041876133
-
Measuring inconsistency in meta-analyses
-
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557-560.
-
(2003)
BMJ
, vol.327
, Issue.7414
, pp. 557-560
-
-
Higgins, J.P.1
Thompson, S.G.2
Deeks, J.J.3
Altman, D.G.4
-
13
-
-
0028659004
-
Operating characteristics of a rank correlation test for publication bias
-
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
-
(1994)
Biometrics
, vol.50
, pp. 1088-1101
-
-
Begg, C.B.1
Mazumdar, M.2
-
14
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315 (7109): 629-634.
-
(1997)
BMJ
, vol.315
, Issue.7109
, pp. 629-634
-
-
Egger, M.1
Davey, S.G.2
Schneider, M.3
Minder, C.4
-
15
-
-
84885907987
-
Statins for the treatment of dementia
-
McGuinness B, O'Hare J, Craig D, Bullock R, Malouf R, Passmore P. Statins for the treatment of dementia. Geriatr Med 2008; 6 (8): CD007514.
-
(2008)
Geriatr Med
, vol.6
, Issue.8
-
-
McGuinness, B.1
O'Hare, J.2
Craig, D.3
Bullock, R.4
Malouf, R.5
Passmore, P.6
-
16
-
-
0036305918
-
The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment
-
Hajjar I, Schumpert J, Hirth V, Wieland D, Eleazer GP. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Gerontol Ser A Biol Sci Med Sci 2002; 57: M414-M418.
-
(2002)
J Gerontol Ser A Biol Sci Med Sci
, vol.57
-
-
Hajjar, I.1
Schumpert, J.2
Hirth, V.3
Wieland, D.4
Eleazer, G.P.5
-
17
-
-
0037456569
-
Prevention of stroke and dementia with statins: effects beyond lipid lowering
-
Carl JV. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol 2003; 91 (Suppl): 23B-29B.
-
(2003)
Am J Cardiol
, vol.91
, Issue.SUPPL
-
-
Carl, J.V.1
-
18
-
-
8644239495
-
Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study
-
Li G, Higdon R, Kukull WA etal. Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology 2004; 63: 1624-1628.
-
(2004)
Neurology
, vol.63
, pp. 1624-1628
-
-
Li, G.1
Higdon, R.2
Kukull, W.A.3
-
19
-
-
13244295723
-
Do statins Reduce Risk of Incident Dementia and Alzheimer Disease?
-
Peter PZ, Larry D, Khachaturian AS etal. Do statins Reduce Risk of Incident Dementia and Alzheimer Disease? Arch Gen Psychiatry 2005; 62: 217-224.
-
(2005)
Arch Gen Psychiatry
, vol.62
, pp. 217-224
-
-
Peter, P.Z.1
Larry, D.2
Khachaturian, A.S.3
-
20
-
-
22844431778
-
Statin use and the risk of incident dementia: the cardiovascular health study
-
Thomas DR, John CB, Bruce MP etal. Statin use and the risk of incident dementia: the cardiovascular health study. Arch Neurol 2005; 62: 1047-1051.
-
(2005)
Arch Neurol
, vol.62
, pp. 1047-1051
-
-
Thomas, D.R.1
John, C.B.2
Bruce, M.P.3
-
21
-
-
34548291482
-
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease
-
Li G, Larson EB, Sonnen JA etal. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 2007; 69: 878-885.
-
(2007)
Neurology
, vol.69
, pp. 878-885
-
-
Li, G.1
Larson, E.B.2
Sonnen, J.A.3
-
22
-
-
67649252917
-
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
-
Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 2008; 71: 344-350.
-
(2008)
Neurology
, vol.71
, pp. 344-350
-
-
Cramer, C.1
Haan, M.N.2
Galea, S.3
Langa, K.M.4
Kalbfleisch, J.D.5
-
23
-
-
58249089520
-
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity
-
Haag M, Hofman A, Koudstaal PJ, Stricker C, Breteler B. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. J Neurol Neurosurg Psychiatry 2009; 80: 13-17.
-
(2009)
J Neurol Neurosurg Psychiatry
, vol.80
, pp. 13-17
-
-
Haag, M.1
Hofman, A.2
Koudstaal, P.J.3
Stricker, C.4
Breteler, B.5
-
24
-
-
58149123594
-
Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials
-
Smeeth L, Douglas I, Hall AJ, Hubbardd R, Evans S. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol 2009; 67: 99-109.
-
(2009)
Br J Clin Pharmacol
, vol.67
, pp. 99-109
-
-
Smeeth, L.1
Douglas, I.2
Hall, A.J.3
Hubbardd, R.4
Evans, S.5
-
25
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
-
The Scandinavian Simvastatin Survival Study Group
-
The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
26
-
-
0028883828
-
Prevention of coronary heart disease in men with hypercholesterolemia
-
for the West of Scotland Coronary Prevention Study Group
-
Shepherd J, Cobbe SM, Ford I etal. for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307.
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
-
27
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
for the Cholesterol and Recurrent Events Trial Investigators
-
Sacks FM, Pfeffer MA, Moye LA etal. for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-1009.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
-
28
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
-
The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
-
The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357.
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
29
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS
-
for the AFCAPS/TexCAPS Research Group
-
Downs JR, Clearfield M, Weis S etal. for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 279: 1615-1622.
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
-
30
-
-
0037202987
-
MRC/BHF Heart Protection Study
-
Robins SJ, Despres JP. MRC/BHF Heart Protection Study. Lancet; 360 (9374): 1780.
-
Lancet
, vol.360
, Issue.9374
, pp. 1780
-
-
Robins, S.J.1
Despres, J.P.2
-
31
-
-
33645743376
-
Cardiovascular disease risk factors and cognitive impairment
-
Nash DT, Fillit H. Cardiovascular disease risk factors and cognitive impairment. Am J Cardiol 2006; 97: 1262-1265.
-
(2006)
Am J Cardiol
, vol.97
, pp. 1262-1265
-
-
Nash, D.T.1
Fillit, H.2
-
32
-
-
23844522541
-
Aggregation of vascular risk factors and risk of incident Alzheimer disease
-
Luchsinger JA, Reitz C, Honig LS etal. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005; 65: 545-551.
-
(2005)
Neurology
, vol.65
, pp. 545-551
-
-
Luchsinger, J.A.1
Reitz, C.2
Honig, L.S.3
-
33
-
-
24344451279
-
Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort
-
Newman AB, Fitzpatrick AL, Lopez O etal. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 2005; 53: 1101-1107.
-
(2005)
J Am Geriatr Soc
, vol.53
, pp. 1101-1107
-
-
Newman, A.B.1
Fitzpatrick, A.L.2
Lopez, O.3
-
34
-
-
0028227379
-
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study
-
Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ 1994; 308 (6944): 1604-1608.
-
(1994)
BMJ
, vol.308
, Issue.6944
, pp. 1604-1608
-
-
Breteler, M.M.1
Claus, J.J.2
Grobbee, D.E.3
Hofman, A.4
-
35
-
-
35948977729
-
Association of statin use with cognitive decline in elderly African Americans
-
Szwast SJ, Hendrie HC, Lane KA etal. Association of statin use with cognitive decline in elderly African Americans. Neurology 2007; 69: 1873-1880.
-
(2007)
Neurology
, vol.69
, pp. 1873-1880
-
-
Szwast, S.J.1
Hendrie, H.C.2
Lane, K.A.3
-
36
-
-
0037388527
-
Reduction in levels of 24S-hydroxycholesterol by statin treatment inpatients with Alzheimer disease
-
Vega GL, Weiner MF, Lipton AM etal. Reduction in levels of 24S-hydroxycholesterol by statin treatment inpatients with Alzheimer disease. Arch Neurol 2003; 60: 510-515.
-
(2003)
Arch Neurol
, vol.60
, pp. 510-515
-
-
Vega, G.L.1
Weiner, M.F.2
Lipton, A.M.3
-
37
-
-
0036714243
-
Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: a 26-week randomized, placebo-controlled, double-blind trial
-
Simons M, Schwarzler F, Lutjohann D etal. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: a 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 2002; 52: 346-350.
-
(2002)
Ann Neurol
, vol.52
, pp. 346-350
-
-
Simons, M.1
Schwarzler, F.2
Lutjohann, D.3
-
38
-
-
18144419392
-
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study
-
Dufouil C, Richard F, Fievet N etal. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 2005; 64: 1531-1538.
-
(2005)
Neurology
, vol.64
, pp. 1531-1538
-
-
Dufouil, C.1
Richard, F.2
Fievet, N.3
-
39
-
-
33645763712
-
Statin use and the risk of Alzheimer's disease: the MIRAGE Study
-
Green RC, McNagny SE, Jayakumar P etal. Statin use and the risk of Alzheimer's disease: the MIRAGE Study. Alzheimers Dement 2006; 2: 96-103.
-
(2006)
Alzheimers Dement
, vol.2
, pp. 96-103
-
-
Green, R.C.1
McNagny, S.E.2
Jayakumar, P.3
-
40
-
-
0036126850
-
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people
-
Rockwood K, Kirkland S, Hogan DB etal. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002; 59: 223-227.
-
(2002)
Arch Neurol
, vol.59
, pp. 223-227
-
-
Rockwood, K.1
Kirkland, S.2
Hogan, D.B.3
-
41
-
-
0033772113
-
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors [see comment]
-
Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors [see comment]. Arch Neurol 2000; 57: 1439-1443.
-
(2000)
Arch Neurol
, vol.57
, pp. 1439-1443
-
-
Wolozin, B.1
Kellman, W.2
Ruosseau, P.3
Celesia, G.G.4
Siegel, G.5
-
42
-
-
0942278990
-
Association between statin use and Alzheimer's disease
-
Zamrini E, McGwin G, Roseman JM. Association between statin use and Alzheimer's disease. Neuroepidemiology 2004; 23: 94-98.
-
(2004)
Neuroepidemiology
, vol.23
, pp. 94-98
-
-
Zamrini, E.1
McGwin, G.2
Roseman, J.M.3
-
43
-
-
27644511663
-
Statins and cognitive function in the elderly. The Cardiovascular Health Study
-
Bernick C, Katz R, Smith NL etal. Statins and cognitive function in the elderly. The Cardiovascular Health Study. Neurology 2005; 65: 1388-1394.
-
(2005)
Neurology
, vol.65
, pp. 1388-1394
-
-
Bernick, C.1
Katz, R.2
Smith, N.L.3
-
44
-
-
20844440894
-
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results
-
Sparks DL, Sabbagh MN, Connor DJ etal. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol 2005; 62: 753-757.
-
(2005)
Arch Neurol
, vol.62
, pp. 753-757
-
-
Sparks, D.L.1
Sabbagh, M.N.2
Connor, D.J.3
-
45
-
-
33645763712
-
Statin use and the risk of Alzheimer's disease: the MIRAGE Study
-
Robert C, Green SE. Statin use and the risk of Alzheimer's disease: the MIRAGE Study. Alzheimers Dement 2006; 2: 96-103.
-
(2006)
Alzheimers Dement
, vol.2
, pp. 96-103
-
-
Robert, C.1
Green, S.E.2
-
47
-
-
78649914200
-
Physical activity and Alzheimer's disease: a meta-analysis of cohort studies
-
Weih M, Degirmenci Ü, Kreil S, Kornhuber J. Physical activity and Alzheimer's disease: a meta-analysis of cohort studies. Gero Psych 2010; 23: 17-20.
-
(2010)
Gero Psych
, vol.23
, pp. 17-20
-
-
Weih, M.1
Degirmenci, U.2
Kreil, S.3
Kornhuber, J.4
-
48
-
-
0037031061
-
MRC/BHF Heat Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
-
MRC/BHF Heat Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
49
-
-
0037164314
-
Pravastatin in Elderly Individuals at Risk of Vascular Disease(PROSPER): a randomised controlled trial
-
Shepherd J, Blauw GJ, Murphy MB etal. Pravastatin in Elderly Individuals at Risk of Vascular Disease(PROSPER): a randomised controlled trial. Lancet 2002; 360: 1623-1630.
-
(2002)
Lancet
, vol.360
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
-
50
-
-
44449115646
-
Cholesterol lowering and beyond: role of statin in Alzheimer's Disease
-
Alba R, Jordi P, Marta A. Cholesterol lowering and beyond: role of statin in Alzheimer's Disease. Aging Health 2008; 4: 171-180.
-
(2008)
Aging Health
, vol.4
, pp. 171-180
-
-
Alba, R.1
Jordi, P.2
Marta, A.3
|